| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Maria Pompea Antonia Baldassarre | Q60322617 |
| Agostino Consoli | Q91035578 | ||
| Ines Bucci | Q92481682 | ||
| Gloria Formoso | Q48329432 | ||
| P2093 | author name string | Federica Ginestra | |
| Maria Assunta Carlucci | |||
| P2860 | cites work | In vivo chiro-inositol metabolism in the rat: a defect in chiro-inositol synthesis from myo-inositol and an increased incorporation of chiro-[3H]inositol into phospholipid in the Goto-Kakizaki (G.K) rat. | Q54131435 |
| Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese type II diabetes. | Q54189909 | ||
| Determination of free α-lipoic acid in foodstuffs by HPLC coupled with CEAD and ESI-MS | Q54283231 | ||
| Modulation of hemodynamic and vascular filtration changes in diabetic rats by dietary myo-inositol. | Q54329203 | ||
| Thioredoxin fragment 31-36 is reduced by dihydrolipoamide and reduces oxidized protein. | Q54754322 | ||
| Myo-inositol in a new pharmaceutical form: a step forward to a broader clinical use. | Q55055690 | ||
| The antioxidant alpha-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. | Q55066548 | ||
| Inositols in Insulin Signaling and Glucose Metabolism | Q60947914 | ||
| Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? | Q71858647 | ||
| Effects of a unique conjugate of alpha-lipoic acid and gamma-linolenic acid on insulin action in obese Zucker rats | Q73426820 | ||
| Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats | Q73515749 | ||
| High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells | Q73542912 | ||
| Lipoic acid prevention of neural tube defects in offspring of rats with streptozocin-induced diabetes | Q77893164 | ||
| Gestational diabetes mellitus | Q78719738 | ||
| Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid | Q79441346 | ||
| Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus | Q80705872 | ||
| Amelioration of lipid abnormalities by α-lipoic acid through antioxidative and anti-inflammatory effects | Q84143689 | ||
| Short-term oral α-lipoic acid does not prevent lipid-induced dysregulation of glucose homeostasis in obese and overweight nondiabetic men | Q84547564 | ||
| Alpha Lipoic Acid (ALA) effects on subchorionic hematoma: preliminary clinical results | Q86390191 | ||
| Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial | Q88723578 | ||
| Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs | Q88957318 | ||
| The influence of different inositol stereoisomers supplementation in pregnancy on maternal gestational diabetes mellitus and fetal outcomes in high-risk patients: a randomized controlled trial | Q90590431 | ||
| Diabetic complications in pregnancy: is resveratrol a solution? | Q27012844 | ||
| Alpha-lipoic acid as a biological antioxidant | Q27863439 | ||
| Beneficial Effects of Tea and the Green Tea Catechin Epigallocatechin-3-gallate on Obesity | Q28067256 | ||
| How effective are antioxidant supplements in obesity and diabetes? | Q28087696 | ||
| Biochemistry and molecular cell biology of diabetic complications | Q28131781 | ||
| Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome | Q28142499 | ||
| Both myo-inositol to chiro-inositol epimerase activities and chiro-inositol to myo-inositol ratios are decreased in tissues of GK type 2 diabetic rats compared to Wistar controls | Q28202966 | ||
| Effects of d-chiro-inositol in lean women with the polycystic ovary syndrome | Q28271889 | ||
| Potential role and therapeutic interests of myo-inositol in metabolic diseases | Q28292692 | ||
| Altered D-chiro-inositol urinary clearance in women with polycystic ovary syndrome | Q28294415 | ||
| A model phosphatase 2C --> phosphatase 1 activation cascade via dual control of inhibitor-1 (INH-1) and DARPP-32 dephosphorylation by two inositol glycan putative insulin mediators from beef liver | Q30303657 | ||
| D-Chiro-Inositol Glycans in Insulin Signaling and Insulin Resistance | Q30434215 | ||
| chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects | Q30454061 | ||
| Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls | Q30457111 | ||
| Postmarketing surveillance of adverse drug reactions: a correlational study approach using multiple data sources | Q33201309 | ||
| Inhibition of vinyl carbamate-induced pulmonary adenocarcinoma by indole-3-carbinol and myo-inositol in A/J mice | Q33615285 | ||
| Determination of urinary Myo-/chiro-inositol ratios from Korean diabetes patients | Q33628262 | ||
| The role of oxidative stress in the pathogenesis of type 2 diabetes: from molecular mechanism to clinical implication. | Q33942082 | ||
| Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases | Q34012029 | ||
| Resveratrol bioavailability and toxicity in humans | Q34020588 | ||
| The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes | Q34026140 | ||
| Inositol safety: clinical evidences. | Q34028175 | ||
| myo-Inositol supplementation and onset of gestational diabetes mellitus in pregnant women with a family history of type 2 diabetes: a prospective, randomized, placebo-controlled study | Q34035221 | ||
| Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle | Q34065020 | ||
| Alpha-lipoic acid inhibits thrombin-induced fetal membrane weakening in vitro | Q34154820 | ||
| Inositols prevent and reverse endothelial dysfunction in diabetic rat and rabbit vasculature metabolically and by scavenging superoxide. | Q34248342 | ||
| Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid | Q34301299 | ||
| α-Lipoic acid protects diabetic apolipoprotein E-deficient mice from nephropathy | Q34440949 | ||
| Resveratrol prevents embryonic oxidative stress and apoptosis associated with diabetic embryopathy and improves glucose and lipid profile of diabetic dam. | Q35022230 | ||
| Beneficial effect of supplemental lipoic acid on diabetes-induced pregnancy loss in the mouse | Q43912167 | ||
| Effects of alpha-lipoic acid supplementation on maternal diabetes-induced growth retardation and congenital anomalies in rat fetuses | Q45054921 | ||
| Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus. | Q45984509 | ||
| Effect of dietary myo-inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial | Q46085298 | ||
| Alpha-lipoic acid reduces congenital malformations in the offspring of diabetic mice | Q46109430 | ||
| Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus | Q46421990 | ||
| Switching from pathogenetic treatment with alpha-lipoic acid to gabapentin and other analgesics in painful diabetic neuropathy: a real-world study in outpatients | Q46651876 | ||
| Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: teratogenicity and reproductive toxicity studies in rats | Q46892599 | ||
| Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus | Q46935436 | ||
| Inositol phosphoglycan putative insulin mediator in human amniotic fluid. | Q46955898 | ||
| Safety of synthetic trans-resveratrol as a novel food pursuant to Regulation (EC) No 258/97 | Q47157595 | ||
| Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders | Q47162682 | ||
| An open-label pilot trial of alpha-lipoic acid for weight loss in patients with schizophrenia without diabetes | Q47249844 | ||
| Effects of alpha-lipoic Acid on body weight in obese subjects | Q47399374 | ||
| Can trans resveratrol plus d-chiro-inositol and myo-inositol improve maternal metabolic profile in overweight pregnant patients? | Q47768063 | ||
| Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial | Q47932349 | ||
| Dietary epigallocatechin 3-gallate supplement improves maternal and neonatal treatment outcome of gestational diabetes mellitus: a double-blind randomised controlled trial. | Q47957737 | ||
| The Prevention of Gestational Diabetes Mellitus With Antenatal Oral Inositol Supplementation: A Randomized Controlled Trial. | Q48096154 | ||
| Abnormalities in myo-inositol metabolism associated with type 2 diabetes in mice fed a high-fat diet: benefits of a dietary myo-inositol supplementation | Q48801302 | ||
| Myo-inositol transport into endothelial cells derived from nervous system microvessels | Q49054165 | ||
| Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis | Q50080683 | ||
| Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. | Q50494276 | ||
| Finding the best therapeutic approach for PCOS: the importance of inositol(s) bioavailability. | Q50525517 | ||
| Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. | Q51027693 | ||
| Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation | Q53101945 | ||
| Centella asiatica and lipoic acid, or a combination thereof, inhibit monocyte adhesion to endothelial cells from umbilical cords of gestational diabetic women. | Q53487033 | ||
| Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction? | Q35034481 | ||
| Increased endothelial inflammation, sTie-2 and arginase activity in umbilical cords obtained from gestational diabetic mothers | Q35078422 | ||
| New Insights on Oxidative Stress and Diabetic Complications May Lead to a “Causal” Antioxidant Therapy | Q35115544 | ||
| Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial | Q35179957 | ||
| Diabetes and alpha lipoic Acid. | Q35564911 | ||
| Effect of α-lipoic acid and exercise training on cardiovascular disease risk in obesity with impaired glucose tolerance. | Q35707591 | ||
| Transplacental supply of mannose and inositol in uncomplicated pregnancies using stable isotopes | Q36069734 | ||
| Myo-Inositol Safety in Pregnancy: From Preimplantation Development to Newborn Animals. | Q36152232 | ||
| Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture | Q36608285 | ||
| D-chiro-inositol metabolism in diabetes mellitus | Q36626417 | ||
| Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve | Q36782199 | ||
| Metabolic changes in pregnancy | Q36992758 | ||
| The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial | Q37019265 | ||
| Alpha-lipoic acid inhibits tumor necrosis factor-induced remodeling and weakening of human fetal membranes | Q37170671 | ||
| The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes. | Q37363630 | ||
| Oxidative stress in diabetes: implications for vascular and other complications | Q37375332 | ||
| Safety and pharmacokinetics of multiple dose myo-inositol in preterm infants | Q37544118 | ||
| Diabetes and obesity in pregnancy | Q37830151 | ||
| The putative metabolic role of d-chiro inositol phosphoglycan in human pregnancy and preeclampsia | Q38130381 | ||
| Peripheral neuropathy in obstetrics: efficacy and safety of α-lipoic acid supplementation. | Q38260441 | ||
| Metabolic effects of resveratrol: addressing the controversies. | Q38303686 | ||
| Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes | Q38342570 | ||
| Inositol transport proteins | Q38394774 | ||
| Alpha-lipoic acid inhibits adipocyte differentiation by regulating pro-adipogenic transcription factors via mitogen-activated protein kinase pathways | Q38520024 | ||
| The influence of D-chiro-inositol and D-myo-inositol in pregnant women with glucose intolerance | Q38626565 | ||
| Protective role of epigallocatechin-3-gallate in health and disease: A perspective | Q38742626 | ||
| Dietary supplementation with myo-inositol in women during pregnancy for treating gestational diabetes. | Q38823728 | ||
| Immunomodulatory activities of alpha lipoic acid with a special focus on its efficacy in preventing miscarriage | Q38854377 | ||
| Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease | Q38879505 | ||
| Epigallocatechin-3-O-gallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition | Q39788941 | ||
| Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect | Q40681688 | ||
| Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway | Q41149722 | ||
| Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial | Q41515750 | ||
| Elevated D-glucose induces insulin insensitivity in human umbilical endothelial cells isolated from gestational diabetic pregnancies | Q42451377 | ||
| Safety of oral alpha-lipoic acid treatment in pregnant women: a retrospective observational study | Q42696763 | ||
| Effects of lipoic acid on AMPK and adiponectin in adipose tissue of low- and high-fat-fed rats | Q42717684 | ||
| Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes | Q42803223 | ||
| Alpha-lipoic acid supplementation: a tool for obesity therapy? | Q43101323 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P433 | issue | 5 | |
| P921 | main subject | gestational diabetes | Q126691 |
| antioxidant | Q133948 | ||
| P304 | page(s) | e3154 | |
| P577 | publication date | 2019-04-10 | |
| 2019-07-01 | |||
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Inositol and antioxidant supplementation: Safety and efficacy in pregnancy | |
| P478 | volume | 35 |
Search more.